Researcher
Karin Thevissen
- Disciplines:Infectious diseases, Mycology
Affiliations
- Microbial and Plant Genetics (CMPG) (Division)
Member
From1 Aug 2020 → Today - Centre of Microbial and Plant Genetics (Division)
Member
From1 Aug 2005 → 31 Jul 2020
Projects
1 - 10 of 27
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Targeting intestinal macrophages as new treatment for Inflammatory Bowel Disease. IBD-MAC.From1 Oct 2021 → 30 Sep 2023Funding: IOF - technology validation in lab
- Sustainable development of a safe & biobased Antimicrobial, Antifungal and Antiviral nanoCOATing platformFrom1 Jun 2021 → 31 May 2023Funding: BOF - various
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Repurposing of existing chemicals as inducers of plant resistance for a more sustainable agriculture.From27 Aug 2019 → 27 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- ‘Bisceps’ Biofilm susceptibility sensors for in situ biofilm monitoring.From1 Jan 2019 → 31 Dec 2022Funding: FWO Strategic Basic Research (SBO)
- Preclinical characterization of miconazole potentiators as novel treatment of biofilm-related infections and epilepsyFrom1 Jan 2018 → 29 Sep 2021Funding: BOF - doctoral mandates
- In vivo validation of the resistance-proof activity of 2-aminoimidazole based anti-biofilm coatings for medical implantsFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- iDAIpps: Indwelling device associated infections: pathology and preventive solutions.From15 Jul 2017 → 14 Jul 2019Funding: BOF - Bilateral scientific cooperation
- Metabolic rewiring in cancer: Pharmacological targeting of serine/glycine synthesis addicted cancersFrom24 May 2017 → 15 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 146
- FLUIDOT: A case study on drug tolerance screening and antibody mining, one cell at a time(2023)
Authors: Karen Ven, Jolien Breukers, Iene Rutten, Maya Imbrechts, Sam Noppen, Dominique Schols, Paul De Munter, Hendrik Jan Thibaut, Karen Vanhoorelbeke, Dragana Spasic, et al.
- FLUIDOT: a Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining(2023)
Authors: Jolien Breukers, Karen Ven, Iene Rutten, Maya Imbrechts, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- Lung epithelial and myeloid innate immunity in influenzaassociated or COVID-19-associated pulmonary aspergillosis: an observational study(2022)
Authors: Simon Feys, Bram Boeckx, Yves Debaveye, Greet Hermans, Stephanie Humblet-Baron, Katrien Lagrou, Laura Seldeslachts, Karin Thevissen, Christophe Vandenbriele, Lore Vanderbeke, et al.
Pages: 1147 - 1159 - Microfluidic platform for the identification and retrieval of single drug-tolerant yeast cells(2022)
Authors: Jolien Breukers, Karen Ven, Iene Rutten, Dragana Spasic, Karin Thevissen, Bruno Cammue, Jeroen Lammertyn
- Development of mesoporous bioactive glass-containing macroporous titanium for controlled release of antimicrobial drugs(2022)
Authors: Nur Hidayatul Nazirah Kamarudin, Karin Thevissen, Annabel Braem
Pages: 1882 - 1895 - Multiplex analysis to unravel the mode of antifungal activity of the plant defensin HsAFP1 in single yeast cells(2022)
Authors: Caroline Struyfs, Jolien Breukers, Dragana Spasic, Jeroen Lammertyn, Bruno Cammue, Karin Thevissen
- Study of the mode of antifungal activity of currently used antimycotics and plant defensins via single cell analysis(2021)
Authors: Caroline Struyfs, Bruno Cammue, Karin Thevissen, Jeroen Lammertyn
- Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host(2021)
Authors: Veronica Llorens-Rico Llorens-Rico, Johan Van Weyenbergh, Sander Jansen, Junbin Qian, Soraya Menezes, Pierre Van Mol, Lore Vanderbeke, Christophe Dooms, Jan Gunst, Greet Hermans, et al.
- The Ketogenic Diet Revisited: Beyond Ketones(2021)
Authors: Jo Sourbron, Karin Thevissen, Lieven Lagae
- Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.(2021)
Authors: Lore Vanderbeke, Pierre Van Mol, Yannick Van Herck, Frederik De Smet, Stephanie Humblet-Baron, Kim Martinod, Ingrid Arijs, Bram Boeckx, Francesca Bosisio, Michael Casaer, et al.
Pages: 4117 - 4117
Patents
1 - 10 of 10
- Idebenone in the treatment of drug resistant epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Treatment of epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Pharmacological targeting of de novo serine/glycine synthesis (Inventor)
- Compositions against candida infections (Inventor)
- Compositions and methods for treating biofilms (Inventor)
- Agents for increased resistance against oxidative stress conditions (Inventor)
- ANTIFUNGAL COMPOUNDS (Inventor)
- ANTIMICROBIAL PEPTIDES (Inventor)